Researchers have identified an enzyme that appears to be a significant regulator of breast cancer development. Called PTPN23, the enzyme can regulate the SRC oncoprotein, providing the basis for a new therapeutic approach.
Researchers have identified an enzyme that appears to be a significant regulator of breast cancer development. Called PTPN23, the enzyme can regulate the SRC oncoprotein, providing the basis for a new therapeutic approach.